Visitect CD4 POC HIV Test11 May 2017 12:30
Yes true and what's more ODX's POC HIV test has USP's that differentiates it from the competition. In fact the 'competition' isn't even direct competition because Visitect CD4 is the only HIV POC test that can be taken out into the most remote areas and no need for returning to lab to get results.
So once we get final validation from field trials and CE marked (all targeted before end 2017) it's a clear runway to accumulating multi million dollar sales and take off for the SP. We know this is now HIGHLY likely and a £1 share price within two years, perhaps less is VERY realistic
DYOR